Skip to main content

Table 2 Patient characteristics of patients after propensity score matching

From: Early administration of glucocorticoid for thyroid storm: analysis of a national administrative database

 

Glucocorticoid group

Control group

ASMD

Number of participants, n

203

203

 

Age(years), median [25th–75th percentiles]

52 [41, 64]

50 [35, 66]

0.08

Sex, female, n (%)

131 (64.5)

127 (62.6)

0.04

Charlson comorbidity index, median

[25th–75th percentiles]

1 [0, 1]

1 [0, 1]

< 0.01

Vasoactive-Inotropic Score (VIS), median [25th–75th percentiles]

0 [0, 0]

0 [0, 0]

0.08

Consciousness, alert, n (%)

57 (50.0)

56 (50.0)

0.03

Defibrillation, n (%)

6 (3.0)

6 (3.0)

< 0.01

Mechanical ventilation use, n (%)

57 (28.1)

52 (25.6)

0.06

Renal replacement therapy, n (%)

6 (3.0)

4 (2.0)

0.06

Extra-corporeal membrane oxygenation, n (%)

4 (2.0)

3 (1.5)

0.05

Intra-aortic balloon pump, n (%)

4 (2.0)

4 (2.0)

< 0.01

Acetaminophen use, n (%)

58 (28.5)

50 (24.6)

0.04

Beta-blockers use, n (%)

108 (53.2)

107 (52.7)

< 0.01

Methimazole use, n (%)

111 (54.7)

112 (55.2)

< 0.01

Potassium Iodide use, n (%)

83 (40.9)

83 (40.9)

0.01

Annual number of patients with thyroid storm per hospital, median [25th–75th percentiles]

7 [4, 10]

7 [3, 10]

0.06

Admission number of ICU each day per hospital, median [25th–75th percentiles]

5.4 [3.3, 7.8]

5.0 [2.9, 7.8]

0.01

Academic hospital, n (%)

46 (22.7)

45 (22.2)

0.01

  1. Abbreviation: ASMD absolute standard mean difference, ICU intensive care unit